Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Hangover Remedy Safety On Tap For FDA Advisory Committees

Executive Summary

CDER schedules an NDAC and DSRMAC joint meeting while also negotiating with industry stakeholders on a potential proposal for a user fee program to support FDA’s work on finalizing monographs or amending monographs with additional ingredients or indications.

Advertisement

Related Content

FDA Should Call Last Round For OTC Hangover Indication, Cmte. Suggests
Recent And Upcoming FDA Advisory Committee Meetings
Recent And Upcoming FDA Advisory Committee Meetings
Recent And Upcoming FDA Advisory Committee Meetings
OTC Monograph User Fees: FDA-Industry Talks Move From Basics To Details
Rulemaking Process Flawed, But Making Monograph Rules Still Needs Funding
OTC Monograph 'Disruption' Could Ride On PDUFA Reauthorization's Back
FDA Denies Remaining Sunscreen TEAs, Offers Primer On GRASE, Resources
OTC Benzocaine Needs Label Warning, Indication Change – Public Citizen
New Home For OTC Drug Review Would Restore Momentum – Hutt, Yingling

Topics

Advertisement
UsernamePublicRestriction

Register

PS120148

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel